Results 291 to 300 of about 1,584,815 (353)
Correction: New diagnostic assays for differential diagnosis between the two distinct lineages of bovine influenza D viruses and human influenza C viruses. [PDF]
Okda FA+4 more
europepmc +1 more source
Advances and Strategies in Enhancing mRNA Cancer Vaccines
Messenger RNA (mRNA) vaccines offer a powerful approach for cancer immunotherapy, but their clinical impact remains limited by delivery challenges and suboptimal immune activation. This review discusses key biological barriers and design strategies—including structural optimization, immunomodulation, organ targeting delivery, and advanced nanocarriers ...
Miao Zhang+4 more
wiley +1 more source
Hospitalizations trends and co-infection patterns for respiratory virus infections in children in central China 2015 to 2023: a longitudinal surveillance study. [PDF]
Dai B+12 more
europepmc +1 more source
Integration of computational and experimental approaches for deciphering the underlying mechanism of biomolecular condensates and potential biomaterials design (Created in Biorender. Raza, Z. (2025) https://BioRender.com/irgmeqi). Abstract Biomolecular condensates, a ubiquitous class of biomaterials found in living cells, have been shown to be ...
Qiang Zhu+10 more
wiley +1 more source
Epidemiological characteristics of influenza after COVID-19 pandemic in Zhejiang province, China. [PDF]
Yang H, Gao Q, Zhan B, Cao G, Yu Z.
europepmc +1 more source
A reprogrammed (RP) phage‐based nanovaccine platform has been developed that allows single‐step assembly with precise control over adjuvanticity, antigen density, and nanoparticle size. By enhancing TLR9 activation and neoantigen display, this platform enables a potent personalized vaccine targeting tumor‐specific neoantigens. When combined with immune
Shengnan Huang+10 more
wiley +1 more source
Clinical Characteristics and Outcome of Jamestown Canyon Virus Infection in Hospitalized Wisconsin Patients. [PDF]
Dumic I+4 more
europepmc +1 more source